Maksim Nikolaevich Yakovlev – St. Petersburg businessman, the Director of group of companies «Poligrafoformlenie”, Director, European representative of biotech Corporation Unhwа and partner online project ‘Edumarket”, which allows stakeholders in the education people get the opportunity to develop your career, and in addition, engage in personal growth.

A future entrepreneur was Born 30 November 1965 in the city of Temirtau (now - Republic of Kazakhstan).

“Poligrafoformlenie”

The Company “Poligrafoformlenie», headed by Maxim Yakovlev 1994, traces its history from the distant 1879, this time saw the creation of E. I. Marcus of chromolithography in Saint-Petersburg, on Vasilievsky island. After the revolution of 1917 the enterprise was renamed into the State Lithography No3, and in 1974 it was the merger with the Printing factory No17, and then appeared a new name - ‘Poligrafoformlenie”. Finally, in 1994, was formed of OJSC “Poligrafoformlenie”, which at the moment is a group of companies.

Today the company is the largest in the North-West of Russia in the production of labels and packaging, and in the state of «Poligrafoformlenie” is more than five hundred employees.

The Company operates in four areas is offset production, production of self-adhesive labels, flexography and packaging method of gravure printing.

Since 2002, the company joined the Global Packaging Alliance. This international organization includes companies from all continents, such as Diamond Packaging, Goncalves, Colorpak, Cartmont and many others.

Today, the ‘Poligrafoformlenie” working with large customers, including many famous brands such as “Baltica”, “Orimi trade”, Wrigley's, Nestle, Dirol, and JTI and BAT.

Unhwa Biotech

Maksim Yakovlev for many years interested in the culture of the East, and thanks to this interest he was able to establish business contacts in Asia. Since 2010, Yakovlev headed the European headquarters of the South Korean Corporation Unhwa biotech called OOO «Unhwa Europe” and is based in St. Petersburg.

The South Korean biotech Corporation develops the technology selection plant stem cell (meristematic Cambial cells) for generating active biological substances for a medicinal and prophylactic preparations and natural cosmetics.

Experts of institutions of science and education, such as The Rockefeller University, Harvard Medecal School and The University of Maryland for Integrative Medicine, confirm that this technology is a big step forward, compared with traditional technologies of cultivation of plant cells for the production of natural products which previously faced the problem of creating a mass production of biologically active substances from cultured plant cells.

The St. Petersburg office of the Corporation, which is headed by Maksim Nikolaevich Yakovlev, works with the aim to bring biotechnology Unhwa on the domestic market. The company plans to build a plant in Russia that will produce biologically active substances from plants.